InnoScience secures CSRC nod to convert 373.84 million domestic shares into H shares

Bulletin Express04-14

InnoScience (Suzhou) Technology Holding Co., Ltd. announced it has received a filing notice from the China Securities Regulatory Commission dated 26 March 2026, confirming completion of the regulatory filing for its H-share full-circulation programme.

The approval covers the conversion of 373.84 million domestic unlisted shares—representing 40.85 % of the company’s total share capital—into H shares for listing and trading on the Main Board of the Hong Kong Stock Exchange. A total of 35 shareholders will participate in the conversion, with the largest blocks held by: • INNOSCIENCE HOLDING PTE. LTD. – 43.00 million shares (4.70 %) • Suzhou Wujiang Industrial Investment Co., Ltd. – 44.75 million shares (4.89 %) • Shenzhen CMB Growth No.17 Equity Investment Fund L.P. – 48.90 million shares (5.34 %)

Under the CSRC notice, the conversion and listing must be completed within 12 months; otherwise, updated filing materials will be required. Final listing remains subject to procedures and approvals from the Hong Kong Stock Exchange and other regulators.

The company stated it will seek listing approval at an appropriate time and will release further updates in accordance with Hong Kong Listing Rules and applicable laws. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment